Highlights Optomed Oyj

Equities

OPTOMED

FI4000410881

Market Closed - Nasdaq Helsinki Other stock markets 11:29:38 2024-05-31 am EDT			5-day change	1st Jan Change
7.27 ^EUR	+10.15%		+12.02%	+95.69%

May. 07	Transcript : Optomed Oyj, Q1 2024 Earnings Call, May 07, 2024
May. 07	Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Optomed USA, Inc. Introduces Optomed Aurora AEYE	May. 01	CI
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod	May. 01	RE
Optomed Plc Announces Optomed Aurora with AEYE Receives U.S. Food & Drug Administration Clearance in US	Apr. 30	CI
Optomed Plc Provides Revenue Guidance for the Full Year of 2024	Apr. 30	CI
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024	Feb. 15	CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Optomed Oyj Provides Revenue Guidance for the Year 2023	Nov. 03	CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain	23-08-18	CI
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Finland's Optomed Enters Distribution Partnership Deal With Thirona Retina	23-05-09	MT
Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
Optomed Plc Provides Revenue Guidance for the Full Year 2023	23-05-05	CI
Optomed Oyj Provides Revenue Guidance for the Full Year of 2023	23-02-17	CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-17	CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
Optomed Oyj Updates Earnings Guidance for the Full Year 2022	22-10-27	CI
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Optomed Oyj

Equities

OPTOMED

FI4000410881

Highlights

Filters